Flaxseed-Based Drug Delivery Systems: Advancing Colon Cancer Treatment


Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2025 | Volume : | | Page : –
    By

    Mohd.Wasiullah,

  • Piyush Yadav,

  • Mohit Vishwakarma,

  • Nidhi Dubey,

  1. Principal, Department of Pharmacy , Prasad Institute of Technology, Jaunpur (222001) U.P., India
  2. Academic Head, Department of Pharmacy , Prasad Institute of Technology, Jaunpur (222001) U.P., India
  3. Scholar, Dept.of Pharmacy,Prasad Institute of Technology, Jaunpur (222001) U.P, India
  4. Scholar, Dept.of Pharmacy,Prasad Institute of Technology, Jaunpur (222001) U.P, India

Abstract

Flaxseed (Linum usitatissimum) has long been appreciated for its rich nutritional profile, including essential fatty acids (such as α-linolenic acid), plant fibers, and lignans. Recent research has focused on its potential as a novel drug delivery system (DDS) for the treatment of colon cancer. This review explores the bioactive constituents of flaxseed, their pharmacological activities, and innovative approaches to the use of flaxseed extracts in drug delivery for the treatment of colon cancer. We highlight the promising pharmacokinetics, target delivery mechanisms, and therapeutic efficacy of flaxseed drug carriers, as well as challenges and future directions in the field. One of the main causes of cancer-related fatalities, colon cancer is a serious worldwide health concern. Effective drug delivery systems (DDS) are essential to target the disease while minimizing systemic toxicity. Flax, a natural product rich in lignans, omega-3 fatty acids, and fiber, has shown promise in cancer treatment due to its anti-inflammatory, antioxidant, and anticarcinogenic properties. This paper investigates the potential of flax extract as a novel drug delivery system (NDDS) for the targeted delivery of chemotherapeuticagents to colon cancer cells. We explore the bioactive compounds of flaxseed, their interactions with drug molecules, and the use of flax-based DDS to improve the bioavailability and therapeutic efficacy of anticancer drugs.

Keywords: Flaxseed, colon cancer, targeted therapy, Linum usitatissimum, Pharmacokinetics of flax-based DDS

How to cite this article:
Mohd.Wasiullah, Piyush Yadav, Mohit Vishwakarma, Nidhi Dubey. Flaxseed-Based Drug Delivery Systems: Advancing Colon Cancer Treatment. Emerging Trends in Personalized Medicines. 2025; ():-.
How to cite this URL:
Mohd.Wasiullah, Piyush Yadav, Mohit Vishwakarma, Nidhi Dubey. Flaxseed-Based Drug Delivery Systems: Advancing Colon Cancer Treatment. Emerging Trends in Personalized Medicines. 2025; ():-. Available from: https://journals.stmjournals.com/etpm/article=2025/view=196699


References

  1. Arora S, Verma RK, Kaur G. Flaxseed: a potential vector for targeted drug delivery in cancer treatment. J Drug Deliv Sci Technol. 2020;58:101810.
  2. Beresford SA, Slattery ML. Flax seeds and their role in the prevention of cancer. Nutr Res Rev. 1994;7(1):39-47.
  3. Prasad S, Gupta SC. Flaxseed extract as a natural anticancer agent: molecular mechanisms and therapeutic potential. Curr Drug Targets. 2018;19(11):1183-93.
  4. Bavarsad S, Ghaffari SH. Flaxseed oil and its components as a therapeutic agent in cancer therapy: a review of recent findings. J Cancer Ther. 2020;11(5):417-32.
  5. Kavitha P, Prakash M. Flaxseed-derived bioactive compounds in cancer prevention and treatment: a review of molecular mechanisms. Cancer Res Treat. 2021;53(4):808-23.
  6. Zhang L, Li S. Development of flaxseed-derived nanocarriers for targeted drug delivery in the treatment of colon cancer. J Drug Deliv Sci Technol. 2019;49:439-48.
  7. Thompson LU, Robb P. Flax and cancer prevention: a review of the literature. J Nutr Biochem. 1991;2(8):414-9.
  8. Prasad S, Gupta SC. Flax extract as a natural anticancer agent: molecular mechanisms and therapeutic potential. Curr Drug Targets. 2018;19(11):1183-93.
  9. Sun J, Wang L. Antioxidant and anticancer effects of linlignans in vitro and in vivo. Food Chem. 2013;139(1-2):212-8.
  10. Boucher S, Goh S. Flaxseed and cancer: review of its anti-inflammatory and antioxidant mechanisms. Lettere di Cancer. 2020;500:69-75.
  11. Jiang L, Yang G. Flax lignans induce apoptosis in colon cancer cells through dependent mitochondria. Mol Carcinog. 2017;56(1):42-55.
  12. Setchell KDR, Cole SJ. Internal standards in the study of phytoestrogens: the role of flaxseed in estrogenic modulation. J Clin Endocrinol Metab. 2003;88(6):2702-7.
  13. Cruz P, Wang Z, Li R. Advances in the use of drug delivery systems based on natural products: flax in cancer treatment. Pharm Dev Technol. 2020;25(6):718-30.
  14. Bachall SM, Lee HJ, Park J. Flax-derived drug delivery systems for targeted treatment of colon cancer: advances and current challenges. J Control Release. 2021;335:356-70.
  15. El-Desoky GE, Zaki RM, El-Mohsen MA. Nanocarrier-based drug delivery systems using linseed oil: a promising platform for the treatment of colon cancer. Nanomedicine. 2022.
  16. Bao Y, Liu Q, Zhao F. Anticancer properties of flax lignans in colon cancer: mechanisms and therapeutic implications. J Nutr Biochem. 2019;63:1-8.
  17. Anticancer properties of lignans and omega-3 fatty acids from flaxseed: molecular mechanisms and therapeutic potential. Front Pharmacol. 2021;12:666478.
  18. Bhardwaj S, Verma P, Sharma RK. Targeted drug delivery systems for colon cancer treatment: Flaxseed as a novel approach. J Drug Deliv Sci Technol. 2022;72:103379.
  19. Chaudhury A, Mahalingam S, Aggarwal P. Liposomal formulations for colon-targeted drug delivery: applications of flaxseed extracts.

Ahead of Print Subscription Review Article
Volume
Received 14/12/2024
Accepted 03/01/2025
Published 01/02/2025


Loading citations…